NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Cash and Bank History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹5.11 Cr | ₹4.97 Cr | ₹1.72 Cr | ₹13 Cr | ₹0.83 Cr |
What is the latest Cash and Bank ratio of NGL FINECHEM ?
| Year | Cash and Bank |
|---|---|
| Mar2026 | ₹5.11 Cr |
| Mar2025 | ₹4.97 Cr |
| Mar2024 | ₹1.72 Cr |
| Mar2023 | ₹13 Cr |
| Mar2022 | ₹0.83 Cr |
How is Cash and Bank of NGL FINECHEM Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.11 Cr | 2.75 | |
| Mar2025 | ₹4.97 Cr | 189.13 | |
| Mar2024 | ₹1.72 Cr | -86.81 | |
| Mar2023 | ₹13 Cr | 1,475.00 | |
| Mar2022 | ₹0.83 Cr | - | |
Compare Cash and Bank of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,796.2 Cr | 4.3% | 3.2% | 110.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 4.3% |
3.2% |
110.2% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses